- Advertise
- About Us
- Editorial Board
- Contact Us
- Job Board
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2026 MJH Life Sciences™ , Infection Control Today – HAIs, Infection Prevention, and Safety News. All rights reserved.
Advanced Technology
The Infection Control Today® advanced technology page allows readers to stay up-to-date on new technologies aimed at preventing infection, such as ultraviolet disinfection, real-time locating systems, foggers, sterilization robots, automation, virtual reality technology during hospital design, and more. Articles and videos focus on explaining the role of these various technologies within the health care system and how infection prevention professionals can integrate them into everyday use.
Aging with HIV: What the Next Major Challenge Is for Drug Development
May 06, 2026
As people with HIV live longer due to ART, new challenges are emerging. Aging with HIV is linked to higher risks of comorbidities, chronic inflammation, and drug interactions, while gaps in clinical trial inclusion and care models highlight the need for more integrated, patient-centered treatment strategies.
Why You Should Attend the 2026 HSPA Annual Conference: Education, Networking, and Real-World SPD Insights
April 08, 2026
The 2026 HSPA Annual Conference offers sterile processing professionals education, networking, and real-world insights, with leaders like Leslie Kronstedt highlighting challenges, mentorship, and opportunities across health care settings.
The Proactive Shift: How AI/Agentic AI Is Revolutionizing Infection Prevention
March 31, 2026
AI and agentic systems are transforming infection prevention by enabling real-time surveillance, predictive risk modeling, and earlier intervention, shifting health care from reactive response to proactive prevention and improving patient safety outcomes.
Marburg Virus Entry Mechanism Reveals New Targets for Antivirals and Infection Prevention Strategies
March 27, 2026
New research shows the Marburg virus enters human cells far more efficiently than Ebola, highlighting increased outbreak risk and underscoring the need for rapid detection, strict infection control, and novel antiviral development.
First-Ever Antibiofilm Drug Enters Phase 2/3 Trial for Prosthetic Joint Infections
March 23, 2026
Peptilogics' PLG0206 represents a breakthrough innovation in infectious disease. First drug designed specifically to penetrate and kill biofilm-protected bacteria. RETAIN Phase 2/3 trial now enrolling patients with prosthetic joint infection. The previous phase showed 93% infection-free rate. It could revolutionize the treatment of medical device-related infections.
Precision Immunotherapy Shows Promise for Improving Organ Dysfunction in Sepsis
March 04, 2026
A multicenter randomized trial of 276 patients with sepsis found that precision immunotherapy targeting immune dysfunction improved organ failure scores by day 9 compared with placebo. Although mortality differences were not statistically significant, the results suggest that biomarker-guided treatment strategies could help personalize sepsis care and improve clinical outcomes.
Cepheid Selected by CDC as National Collaborator to Accelerate Rapid Diagnostic Development for Future Pandemics
February 19, 2026
Cepheid has been selected by the CDC as a national collaborator to accelerate rapid diagnostic development during public health emergencies. With early access to outbreak samples and genomic data, the company aims to shorten response timelines and strengthen U.S. pandemic preparedness through scalable, high accuracy PCR testing solutions.
Engineered Phages in Infection Prevention: What Is Realistic for Hospitals Now
February 16, 2026
Could engineered bacteriophages help hospitals tackle drug-resistant infections when antibiotics fail? In this ICT Q&A, researchers discuss where phage engineering may realistically fit first in hospitals, from treatment of MDR infections to environmental control, and why broad-coverage phage products remain a longer-term goal.